Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -41.18%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.14 per share when it actually produced a loss of $0.19, delivering a surprise of -35.71%.Over the last four ...